Bio Essence annual ebitda
2020
2021
2022
2023
2024
2025
Bio Essence EBITDA Growth & History (BIOE)
Bio Essence's calculated EBITDA was $900,246 for fiscal 2025.
View full Bio Essence company overviewBio Essence annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $900,246 | $1.4M | — |
| 2024 | 2024-12-31 | −$458,527 | −$117,730 | — |
| 2023 | 2023-12-31 | −$340,797 | $155,828 | — |
| 2022 | 2022-12-31 | −$496,625 | $325,100 | — |
| 2021 | 2021-12-31 | −$821,725 | −$22,439 | — |
| 2020 | 2020-12-31 | −$799,286 | — | — |
Bio Essence quarterly ebitda
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $382,890 | $321,608 | +524.80% |
| Q1 2026 | 2026-03-31 | $215,854 | $420,887 | — |
| Q4 2025 | 2025-12-31 | $1.0M | $1.0M | +26241.42% |
| Q3 2025 | 2025-09-30 | $14,311 | $160,700 | — |
| Q2 2025 | 2025-06-30 | $61,282 | $225,998 | — |
| Q1 2025 | 2025-03-31 | −$205,033 | −$53,702 | — |
| Q4 2024 | 2024-12-31 | $3,909 | $173,984 | — |
| Q3 2024 | 2024-09-30 | −$146,389 | −$38,331 | — |
| Q2 2024 | 2024-06-30 | −$164,716 | −$123,882 | — |
| Q1 2024 | 2024-03-31 | −$151,331 | −$129,501 | — |
| Q4 2023 | 2023-12-31 | −$170,075 | −$210,679 | — |
| Q3 2023 | 2023-09-30 | −$108,058 | $69,221 | — |
| Q2 2023 | 2023-06-30 | −$40,834 | $103,558 | — |
| Q1 2023 | 2023-03-31 | −$21,830 | $193,728 | — |
| Q4 2022 | 2022-12-31 | $40,604 | $229,573 | — |
| Q3 2022 | 2022-09-30 | −$177,279 | $6,957 | — |
| Q2 2022 | 2022-06-30 | −$144,392 | $108,112 | — |
| Q1 2022 | 2022-03-31 | −$215,558 | −$19,542 | — |
| Q4 2021 | 2021-12-31 | −$188,969 | $131,390 | — |
| Q3 2021 | 2021-09-30 | −$184,236 | −$5,246 | — |
| Q2 2021 | 2021-06-30 | −$252,504 | −$64,572 | — |
| Q1 2021 | 2021-03-31 | −$196,016 | −$84,011 | — |
| Q4 2020 | 2020-12-31 | −$320,359 | — | — |
| Q3 2020 | 2020-09-30 | −$178,990 | — | — |
| Q2 2020 | 2020-06-30 | −$187,932 | — | — |
| Q1 2020 | 2020-03-31 | −$112,005 | — | — |
Bio Essence ebitda trends
Over the last five reported fiscal years, Bio Essence's ebitda increased from −$799,286 to $900,246, a change of $1.7M. The latest reported quarter, Q2 2026, shows $382,890.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bio Essence filings at SEC.gov ↗